SLI
2.006,88
PKT
+4,26
PKT
+0,21
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.11.05 | Zurich Insurance halten | Helaba Trust | |
| 15.11.05 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 16.11.05 | Swiss Life kaufen | Nord LB | |
| 15.11.05 | Zurich Insurance buy | Bank Sarasin & Cie | |
| 14.11.05 | Swiss Life buy | Merck Finck & Co | |
| 15.11.05 | Novartis | DZ-Bank | |
| 15.11.05 | UBS | DZ-Bank | |
| 14.11.05 | Swisscom underperform | Goldman Sachs | |
| 10.11.05 | Novartis | Zürcher Kantonalbank | |
| 09.11.05 | UBS neutral | Merrill Lynch | |
| 09.11.05 | Novartis overweight | Lehman Brothers | |
| 08.11.05 | UBS halten | Hamburger Sparkasse | |
| 08.11.05 | Novartis buy | Jyske Bank | |
| 29.11.05 | Nestlé kaufen | Bank Hofmann | |
| 04.11.05 | UBS | DZ-Bank | |
| 04.11.05 | Novartis buy | Jefferies & Co | |
| 07.11.05 | Zurich Insurance neutral | JP Morgan | |
| 03.11.05 | Novartis Buy | Jefferies & Co | |
| 03.11.05 | Swiss Life | Nebenwerte Journal | |
| 04.11.05 | UBS neutral | JP Morgan | |
| 03.11.05 | Kühne + Nagel International | Focus Money | |
| 02.11.05 | UBS halten | Helaba Trust | |
| 03.11.05 | UBS overweight | JP Morgan | |
| 02.11.05 | UBS overweight | Morgan Stanley | |
| 01.11.05 | UBS kaufen | Helaba Trust | |
| 01.11.05 | UBS buy | SEB | |
| 01.11.05 | UBS akkumulieren | Independent Research | |
| 02.11.05 | ABB (Asea Brown Boveri) kaufen | Hamburger Sparkasse | |
| 31.10.05 | Holcim verkaufen | Helaba Trust | |
| 04.11.05 | ABB (Asea Brown Boveri) kaufen | National-Bank AG | |
| 28.10.05 | UBS | DZ-Bank | |
| 28.10.05 | Novartis | DZ-Bank | |
| 28.10.05 | ABB (Asea Brown Boveri) halten | Helaba Trust | |
| 28.10.05 | Novartis kaufen | Berenberg Bank | |
| 28.10.05 | Novartis | Wirtschaftswoche | |
| 28.10.05 | Holcim | Fuchsbriefe | |
| 27.10.05 | Nestlé | Zürcher Kantonalbank | |
| 28.10.05 | Nestlé buy | Bank Sarasin & Cie | |
| 26.10.05 | Novartis Hold | Deutsche Securities | |
| 26.10.05 | Nestlé kaufen | Banque SYZ & CO |